BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 14663456)

  • 1. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers.
    Markowitz JS; Donovan JL; Devane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
    Clin Pharmacol Ther; 2003 Dec; 74(6):536-42. PubMed ID: 14663456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers.
    Donovan JL; DeVane CL; Chavin KD; Taylor RM; Markowitz JS
    Drug Metab Dispos; 2003 May; 31(5):519-22. PubMed ID: 12695337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme.
    Markowitz JS; Donovan JL; DeVane CL; Taylor RM; Ruan Y; Wang JS; Chavin KD
    JAMA; 2003 Sep; 290(11):1500-4. PubMed ID: 13129991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers.
    Markowitz JS; Donovan JL; Lindsay DeVane C; Sipkes L; Chavin KD
    J Clin Psychopharmacol; 2003 Dec; 23(6):576-81. PubMed ID: 14624188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of garlic (Allium sativum L.) supplementation on cytochrome P450 2D6 and 3A4 activity in healthy volunteers.
    Markowitz JS; Devane CL; Chavin KD; Taylor RM; Ruan Y; Donovan JL
    Clin Pharmacol Ther; 2003 Aug; 74(2):170-7. PubMed ID: 12891227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers.
    Donovan JL; DeVane CL; Chavin KD; Wang JS; Gibson BB; Gefroh HA; Markowitz JS
    Drug Metab Dispos; 2004 Dec; 32(12):1333-6. PubMed ID: 15328251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers.
    Donovan JL; Chavin KD; Devane CL; Taylor RM; Wang JS; Ruan Y; Markowitz JS
    Drug Metab Dispos; 2004 Sep; 32(9):906-8. PubMed ID: 15319329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of St. John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers.
    Markowitz JS; DeVane CL; Boulton DW; Carson SW; Nahas Z; Risch SC
    Life Sci; 2000 Jan; 66(9):PL133-9. PubMed ID: 10698361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmetto.
    Gurley BJ; Gardner SF; Hubbard MA; Williams DK; Gentry WB; Carrier J; Khan IA; Edwards DJ; Shah A
    Clin Pharmacol Ther; 2004 Nov; 76(5):428-40. PubMed ID: 15536458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of cytochrome P450 3A4/5 activity in vivo with dextromethorphan N-demethylation.
    Jones DR; Gorski JC; Haehner BD; O'Mara EM; Hall SD
    Clin Pharmacol Ther; 1996 Oct; 60(4):374-84. PubMed ID: 8873685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the inhibitory potential of Ginkgo biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9.
    Yale SH; Glurich I
    J Altern Complement Med; 2005 Jun; 11(3):433-9. PubMed ID: 15992226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sex differences in 3,4-methylenedioxymethamphetamine (MDMA; ecstasy)-induced cytochrome P450 2D6 inhibition in humans.
    Yubero-Lahoz S; Pardo R; Farré M; O'Mahony B; Torrens M; Mustata C; Pérez-Mañá C; Carbó ML; de la Torre R
    Clin Pharmacokinet; 2011 May; 50(5):319-29. PubMed ID: 21456632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative contribution to dextromethorphan metabolism by cytochrome P450 isoforms in vitro: can dextromethorphan be used as a dual probe for both CTP2D6 and CYP3A activities?
    Yu A; Haining RL
    Drug Metab Dispos; 2001 Nov; 29(11):1514-20. PubMed ID: 11602530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of multiple dosing effect of sertindole on the pharmacokinetics of alprazolam in healthy volunteers.
    Wong SL; Locke C; Staser J; Granneman GR
    Psychopharmacology (Berl); 1998 Feb; 135(3):236-41. PubMed ID: 9498726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome p450 3A4 messenger ribonucleic acid induction by rifampin in human peripheral blood mononuclear cells: correlation with alprazolam pharmacokinetics.
    Gashaw I; Kirchheiner J; Goldammer M; Bauer S; Seidemann J; Zoller K; Mrozikiewicz PM; Roots I; Brockmöller J
    Clin Pharmacol Ther; 2003 Nov; 74(5):448-57. PubMed ID: 14586385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of gender differences and large intrasubject variability in cytochrome P450 activity measured by phenotyping with dextromethorphan.
    McCune JS; Lindley C; Decker JL; Williamson KM; Meadowcroft AM; Graff D; Sawyer WT; Blough DK; Pieper JA
    J Clin Pharmacol; 2001 Jul; 41(7):723-31. PubMed ID: 11452704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A urine metabolic ratio of dextromethorphan and 3-methoxymorphinan as a probe for CYP3A activity and prediction of cyclosporine clearance in healthy volunteers.
    Min DI; Ku YM; Vichiendilokkul A; Fleckenstein LL
    Pharmacotherapy; 1999 Jun; 19(6):753-9. PubMed ID: 10391422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism.
    Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T
    Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of low-dose ritonavir (100 mg twice daily) on the activity of cytochrome P450 2D6 in healthy volunteers.
    Aarnoutse RE; Kleinnijenhuis J; Koopmans PP; Touw DJ; Wieling J; Hekster YA; Burger DM
    Clin Pharmacol Ther; 2005 Dec; 78(6):664-74. PubMed ID: 16338282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.